BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28728962)

  • 41. Increasing eligibility for nipple-sparing mastectomy.
    Coopey SB; Tang R; Lei L; Freer PE; Kansal K; Colwell AS; Gadd MA; Specht MC; Austen WG; Smith BL
    Ann Surg Oncol; 2013 Oct; 20(10):3218-22. PubMed ID: 23975296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncological safety of therapeutic 'nipple-sparing mastectomy' followed by reconstruction: a systematic review.
    Blanckaert M; Vranckx J
    Acta Chir Belg; 2021 Jun; 121(3):155-163. PubMed ID: 33929924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.
    Özkurt E; Tükenmez M; Güven E; Çelet Özden B; Öner G; Müslümanoğlu M; İğci A; Özmen V; Küçücük S; Cabioğlu N
    Balkan Med J; 2018 Jan; 35(1):84-92. PubMed ID: 28958980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy?
    Lohsiriwat V; Rotmensz N; Botteri E; Intra M; Veronesi P; Martella S; Garusi C; De Lorenzi F; Manconi A; Lomeo G; Rietjens M; Schorr M; Kneubil MC; Petit JY
    Ann Surg Oncol; 2013 Mar; 20(3):990-6. PubMed ID: 23070785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Oncological safety and prognosis factors analysis of immediate breast reconstruction after nipple-areola-complex sparing mastectomy].
    Li ZJ; Zhang P; Zhang W; Zhang Z; Wang XM; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):690-695. PubMed ID: 30293396
    [No Abstract]   [Full Text] [Related]  

  • 46. Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer Patients.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Jakub JW; Krajewski AC; Jacobson SR; Hieken TJ
    Am J Surg; 2017 Apr; 213(4):810-813. PubMed ID: 27692794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year period.
    Orzalesi L; Casella D; Santi C; Cecconi L; Murgo R; Rinaldi S; Regolo L; Amanti C; Roncella M; Serra M; Meneghini G; Bortolini M; Altomare V; Cabula C; Catalano F; Cirilli A; Caruso F; Lazzaretti MG; Cataliotti L; Bernini M
    Breast; 2016 Feb; 25():75-81. PubMed ID: 26612083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncologic Trends, Outcomes, and Risk Factors for Locoregional Recurrence: An Analysis of Tumor-to-Nipple Distance and Critical Factors in Therapeutic Nipple-Sparing Mastectomy.
    Frey JD; Salibian AA; Lee J; Harris K; Axelrod DM; Guth AA; Shapiro RL; Schnabel FR; Karp NS; Choi M
    Plast Reconstr Surg; 2019 Jun; 143(6):1575-1585. PubMed ID: 30907805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical and Oncologic Outcomes of Nipple-Sparing Mastectomy for a Cohort of Breast Cancer Patients, Including Cases with High-Risk Features.
    Parvez E; Martel K; Morency D; Dumitra S; Meguerditchian AN; Dionisopoulos T; Meterissian S; Basik M; Boileau JF
    Clin Breast Cancer; 2020 Aug; 20(4):353-358. PubMed ID: 32305298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution.
    Sakurai T; Zhang N; Suzuma T; Umemura T; Yoshimura G; Sakurai T; Yang Q
    Med Oncol; 2013 Mar; 30(1):481. PubMed ID: 23377926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?
    Didier F; Arnaboldi P; Gandini S; Maldifassi A; Goldhirsch A; Radice D; Minotti I; Ballardini B; Luini A; Santillo B; Rietjens M; Petit JY
    Breast Cancer Res Treat; 2012 Apr; 132(3):1177-84. PubMed ID: 22350788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up.
    Webster AJ; Shanno JN; Santa Cruz HS; Kelly BN; Garstka M; Henriquez A; Specht MC; Gadd MA; Verdial FC; Nguyen A; Oseni TO; Coopey SB; Smith BL
    Ann Surg Oncol; 2023 Jun; 30(6):3215-3222. PubMed ID: 36604360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary Buttonhole Mastopexy and Nipple-Sparing Mastectomy: A Preliminary Report.
    Salibian AH; Harness JK; Mowlds DS
    Ann Plast Surg; 2016 Oct; 77(4):388-95. PubMed ID: 26418778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
    Manning AT; Wood C; Eaton A; Stempel M; Capko D; Pusic A; Morrow M; Sacchini V
    Br J Surg; 2015 Oct; 102(11):1354-9. PubMed ID: 26313374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy.
    Santoro S; Loreti A; Cavaliere F; Costarelli L; La Pinta M; Manna E; Mauri M; Scavina P; Santini E; De Paula U; Toto V; Fortunato L
    Breast; 2015 Oct; 24(5):661-6. PubMed ID: 26343944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcome and patient satisfaction with the use of bovine-derived acellular dermal matrix (SurgiMend™) in implant based immediate reconstruction following skin sparing mastectomy: A prospective observational study in a single centre.
    Headon H; Kasem A; Manson A; Choy C; Carmichael AR; Mokbel K
    Surg Oncol; 2016 Jun; 25(2):104-10. PubMed ID: 27312036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nipple skin-sparing mastectomy is feasible for advanced disease.
    Burdge EC; Yuen J; Hardee M; Gadgil PV; Das C; Henry-Tillman R; Ochoa D; Korourian S; Suzanne Klimberg V
    Ann Surg Oncol; 2013 Oct; 20(10):3294-302. PubMed ID: 23975304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.
    Valero MG; Moo TA; Muhsen S; Zabor EC; Stempel M; Pusic A; Gemignani ML; Morrow M; Sacchini V
    Br J Surg; 2020 Sep; 107(10):1307-1312. PubMed ID: 32432359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The oncological safety of nipple-sparing mastectomy - a Swedish matched cohort study.
    Adam H; Bygdeson M; de Boniface J
    Eur J Surg Oncol; 2014 Oct; 40(10):1209-15. PubMed ID: 25186915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.